Literature DB >> 8320979

AIDA2: a Mk. II automated insulin dosage advisor.

E D Lehmann1, T Deutsch.   

Abstract

A prototype computer system has been developed to provide advice on the day-to-day adjustment of insulin dosage in the insulin-dependent (type 1) diabetic patient. The system also allows the patient's daily steady-state blood glucose profile to be generated based on these adjustments using a clinical model of glucose-insulin interaction. The prototype is intended to be used as a decision support system by clinical personnel. It is designed for use during consultations, as a simulator of patient response following changes in the insulin and/or dietary regimen, and as a system to provide education on planning insulin therapy. Advice is generated by a qualitative therapeutic advisor which suggests what the next step in improving glycaemic control might be for a given patient. The clinical model attempts to reflect the underlying (patho)physiology of insulin action and carbohydrate absorption in quantitative terms. It consists of a one-compartment glucose model linked to a model with plasma and 'active' insulin compartments. An overview of the integrated prototype is provided along with a detailed description of the new time-point-orientated logical reasoning methodology adopted by the therapeutic advisor. The operation of the system is illustrated by a clinical case study from a 70 kg, male, insulin-dependent diabetic patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8320979     DOI: 10.1016/0141-5425(93)90116-g

Source DB:  PubMed          Journal:  J Biomed Eng        ISSN: 0141-5425


  6 in total

1.  Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

2.  A neural network approach in diabetes management by insulin administration.

Authors:  G Gogou; N Maglaveras; B V Ambrosiadou; D Goulis; C Pappas
Journal:  J Med Syst       Date:  2001-04       Impact factor: 4.460

3.  In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le Compte; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

4.  A subcutaneous insulin pharmacokinetic model for computer simulation in a diabetes decision support role: model structure and parameter identification.

Authors:  Jason Wong; J Geoffrey Chase; Christopher E Hann; Geoffrey M Shaw; Thomas F Lotz; Jessica Lin; Aaron J Le Compte
Journal:  J Diabetes Sci Technol       Date:  2008-07

5.  Validation of a model-based virtual trials method for tight glycemic control in intensive care.

Authors:  J Geoffrey Chase; Fatanah Suhaimi; Sophie Penning; Jean-Charles Preiser; Aaron J Le Compte; Jessica Lin; Christopher G Pretty; Geoffrey M Shaw; Katherine T Moorhead; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2010-12-14       Impact factor: 2.819

Review 6.  Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.

Authors:  J Geoffrey Chase; Jean-Charles Preiser; Jennifer L Dickson; Antoine Pironet; Yeong Shiong Chiew; Christopher G Pretty; Geoffrey M Shaw; Balazs Benyo; Knut Moeller; Soroush Safaei; Merryn Tawhai; Peter Hunter; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2018-02-20       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.